Silverback Therapeutics Inc (SBTX)


Stock Price Forecast

Nov. 8, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Silverback Therapeutics Inc chart...

About the Company

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

Exchange

NASDAQ

Website

silverbacktx.com

$M

Total Revenue

54

Employees

$211M

Market Capitalization

-1.59

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SBTX News

Buy Rating on ARS Pharmaceuticals Amid Strong neffy Approval Prospects and Indication Expansion

3d ago, source:

In a report released on March 21, Roanna Ruiz from Leerink Partners maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research ...

IPO Launch: Silverback Therapeutics Finalizes $125 Million IPO Effort

3y ago, source: TheStreet.com

Silverback Therapeutics (SBTX) aims to raise $125 million from the sale of its common stock in an IPO, according to an amended registration statement. Seattle, Washington-based Silverback was ...

Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M

on MSN ago, source:

Local biotech Capstan Therapeutics exceeded its fundraising goal by $50 million despite a tough venture capital environment.

ARS Pharmaceuticals Inc (SPRY)

2d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why

1d ago, source:

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is ...

Silverback Therapeutics Announces Pricing of Initial Public Offering

1mon ago, source: ADVFN

Silverback Therapeutics, Inc. (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue ...

Presidio Management Group XII, L.L.C.'s Net Worth

26d ago, source: Benzinga.com

Who is Presidio Management Group XII, L.L.C.? Presidio Management Group XII, L.L.C. has an estimated net worth of $13 Million. This is based on reported shares in Silverback Therapeutics, Inc..

CMPX Compass Therapeutics, Inc.

22h ago, source: Seeking Alpha

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States.

Omega Therapeutics Inc OMGA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Kintara Therapeutics Inc KTRA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

ARS Pharmaceuticals Inc (SPRY)

1mon ago, source: Investing

SAN DIEGO - ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) announced today that its investigational drug neffy, an epinephrine nasal spray, has shown positive results in a phase 2 study ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...